Rage mounts against pharma corp. that jacked cost of life-saving EpiPen by 400%

(credit: Phillip Bradshaw)

When someone like Martin Shkreli fingers your company as greedy “vultures,” you know you’ve got problems.

For pharmaceutical company Mylan, which hiked the price of life-saving EpiPens by 400 percent since it bought the product in 2007, Shkreli’s is just one of the voices in a chorus of scorn now facing the company.

On Wednesday, presidential candidate Hillary Clinton and the American Medical Association (AMA) separately called on Mylan to lower the cost of the auto-injecting pens, which reverse deadly allergic reactions. Also Wednesday, Bernie Sanders (I-Vt.) took to Facebook to declare “Mylan’s greed is apparently limitless.” The rebukes follow a steady stream of other Congress members who have questioned and expressed concern over the price increase.


Scientific Method – Ars Technica



Please enter your comment!
Please enter your name here